Summit Trail Advisors, LLC Esperion Therapeutics, Inc. Transaction History

Summit Trail Advisors, LLC

  • $3.76 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$40.74 - $51.41 $21,184 - $26,733
-520 Closed
0 $0
Q2 2018

Aug 10, 2018
SELL
$36.2 - $76.4 $805,232 - $1.7 Million
-22,244 Reduced 97.72%
520 $20,000
Q1 2018

May 21, 2018
BUY
$65.94 - $80.76 $1.41 Million - $1.72 Million
21,314 Added 1469.93%
22,764 $23,000
Q4 2017

Feb 14, 2018
BUY
$43.47 - $67.43 $63,031 - $97,773
1,450
1,450 $101,000

Others Institutions Holding ESPR

# of Institutions
199
Shares Held
136M
Call Options Held
2.72M
Put Options Held
1.3M
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $109M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email